Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Automated processing of ELISA
Connect with this vendor - Learn about this product

COVID-19 diagnostics: PCR and ELISAs

EURORealTime SARS-CoV-2

  • CE-marked PCR test for direct detection of SARS-CoV-2
  • High sensitivity and reliability due to simultaneous detection of two target sequences
  • Only one reaction per sample

Anti-SARS-CoV-2 ELISA (IgG)

  • CE-marked ELISA based on spike protein domain S1
  • Includes the immunologically relevant receptor binding domain
  • High specificity (99.6%) due to low homology of S1 within the coronavirus family
  • Suitable for detection of recent or past contact with SARS-CoV-2
  • Fully automatable

Anti-SARS-CoV-2 NCP ELISA (IgG)

  • CE-marked ELISA based on modified nucleocapsid protein
  • Only diagnostically relevant epitopes are used – for optimized performance in comparison to full length N protein
  • High specificity (99.8%) due to removal of unspecific epitopes
  • Suitable for detection of recent or past contact with SARS-CoV-2
  • Fully automatable

Anti-SARS-CoV-2 ELISA (IgA)

  • CE-marked ELISA based on spike protein domain S1
  • Suitable for monitoring a developing immune response after positive direct detection
  • Fully automatable